Preoperative intravitreal Ranibizumab with panretinal photocoagulation followed by conventional trabeculectomy without drainage device for neovascular glaucoma

AIM: To evaluate the efficacy and safety of preoperative intravitreal injection of ranibizumab(IVR)and panretinal photocoagulation(PRP)combined with conventional trabeculectomy without drainage device in patients with neovascular glaucoma(NVG).METHODS: The charts of 27 patients(27 eyes)who presented...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiao-Dong Han, Li Meng, Xiao-Jin Chen, Zhan-Jun Yan, Ke-Wei Song
Formato: article
Lenguaje:EN
Publicado: Press of International Journal of Ophthalmology (IJO PRESS) 2021
Materias:
Acceso en línea:https://doaj.org/article/464d0a25ec7d49b2a270879895862748
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:464d0a25ec7d49b2a270879895862748
record_format dspace
spelling oai:doaj.org-article:464d0a25ec7d49b2a2708798958627482021-11-22T14:22:32ZPreoperative intravitreal Ranibizumab with panretinal photocoagulation followed by conventional trabeculectomy without drainage device for neovascular glaucoma1672-512310.3980/j.issn.1672-5123.2021.12.02https://doaj.org/article/464d0a25ec7d49b2a2708798958627482021-12-01T00:00:00Zhttp://ies.ijo.cn/cn_publish/2021/12/202112002.pdfhttps://doaj.org/toc/1672-5123AIM: To evaluate the efficacy and safety of preoperative intravitreal injection of ranibizumab(IVR)and panretinal photocoagulation(PRP)combined with conventional trabeculectomy without drainage device in patients with neovascular glaucoma(NVG).METHODS: The charts of 27 patients(27 eyes)who presented with NVG in our hospital between August 2015 and November 2018 were reviewed. All eyes were treated using the standard protocol of IVR accompanied by PRP, followed by conventional trabeculectomy without drainage device. The main outcomes were intraocular pressure(IOP)control, change in best-corrected visual acuity(BCVA), and surgical complications.RESULTS: The postoperative follow-up periods for all patients were at least 18(mean 21.7±4.3)mo. The IOP significantly decreased from 45.7±5.1 mmHg(baseline)to 18.4±3.6 mmHg(last visit), and BCVA(LogMAR)improved from 2.42±0.68(baseline)to 1.77±0.93(last visit). The success rate was higher in eyes with peripheral anterior synechiae(PAS)≤50% than in those with PAS >50% after 3mo postoperatively. The main surgical complications were hyphema(11.1%)and hypotony with a shallow anterior chamber(14.8%)during the early postoperative stage, along with encapsulated bleb(37.0%)during the mid-late postoperative stage. Serious intraoperative or postoperative complications were not observed.CONCLUSION: IVR and PRP combined with conventional trabeculectomy without drainage device is a safe and effective way in NVG treatment, especially for eyes with PAS ≤50%. Preoperative IVR and PRP appear to improve the success rate.Xiao-Dong HanLi MengXiao-Jin ChenZhan-Jun YanKe-Wei SongPress of International Journal of Ophthalmology (IJO PRESS)articleneovascular glaucomaranibizumabpanretinal photocoagulationtrabeculectomyOphthalmologyRE1-994ENGuoji Yanke Zazhi, Vol 21, Iss 12, Pp 2026-2031 (2021)
institution DOAJ
collection DOAJ
language EN
topic neovascular glaucoma
ranibizumab
panretinal photocoagulation
trabeculectomy
Ophthalmology
RE1-994
spellingShingle neovascular glaucoma
ranibizumab
panretinal photocoagulation
trabeculectomy
Ophthalmology
RE1-994
Xiao-Dong Han
Li Meng
Xiao-Jin Chen
Zhan-Jun Yan
Ke-Wei Song
Preoperative intravitreal Ranibizumab with panretinal photocoagulation followed by conventional trabeculectomy without drainage device for neovascular glaucoma
description AIM: To evaluate the efficacy and safety of preoperative intravitreal injection of ranibizumab(IVR)and panretinal photocoagulation(PRP)combined with conventional trabeculectomy without drainage device in patients with neovascular glaucoma(NVG).METHODS: The charts of 27 patients(27 eyes)who presented with NVG in our hospital between August 2015 and November 2018 were reviewed. All eyes were treated using the standard protocol of IVR accompanied by PRP, followed by conventional trabeculectomy without drainage device. The main outcomes were intraocular pressure(IOP)control, change in best-corrected visual acuity(BCVA), and surgical complications.RESULTS: The postoperative follow-up periods for all patients were at least 18(mean 21.7±4.3)mo. The IOP significantly decreased from 45.7±5.1 mmHg(baseline)to 18.4±3.6 mmHg(last visit), and BCVA(LogMAR)improved from 2.42±0.68(baseline)to 1.77±0.93(last visit). The success rate was higher in eyes with peripheral anterior synechiae(PAS)≤50% than in those with PAS >50% after 3mo postoperatively. The main surgical complications were hyphema(11.1%)and hypotony with a shallow anterior chamber(14.8%)during the early postoperative stage, along with encapsulated bleb(37.0%)during the mid-late postoperative stage. Serious intraoperative or postoperative complications were not observed.CONCLUSION: IVR and PRP combined with conventional trabeculectomy without drainage device is a safe and effective way in NVG treatment, especially for eyes with PAS ≤50%. Preoperative IVR and PRP appear to improve the success rate.
format article
author Xiao-Dong Han
Li Meng
Xiao-Jin Chen
Zhan-Jun Yan
Ke-Wei Song
author_facet Xiao-Dong Han
Li Meng
Xiao-Jin Chen
Zhan-Jun Yan
Ke-Wei Song
author_sort Xiao-Dong Han
title Preoperative intravitreal Ranibizumab with panretinal photocoagulation followed by conventional trabeculectomy without drainage device for neovascular glaucoma
title_short Preoperative intravitreal Ranibizumab with panretinal photocoagulation followed by conventional trabeculectomy without drainage device for neovascular glaucoma
title_full Preoperative intravitreal Ranibizumab with panretinal photocoagulation followed by conventional trabeculectomy without drainage device for neovascular glaucoma
title_fullStr Preoperative intravitreal Ranibizumab with panretinal photocoagulation followed by conventional trabeculectomy without drainage device for neovascular glaucoma
title_full_unstemmed Preoperative intravitreal Ranibizumab with panretinal photocoagulation followed by conventional trabeculectomy without drainage device for neovascular glaucoma
title_sort preoperative intravitreal ranibizumab with panretinal photocoagulation followed by conventional trabeculectomy without drainage device for neovascular glaucoma
publisher Press of International Journal of Ophthalmology (IJO PRESS)
publishDate 2021
url https://doaj.org/article/464d0a25ec7d49b2a270879895862748
work_keys_str_mv AT xiaodonghan preoperativeintravitrealranibizumabwithpanretinalphotocoagulationfollowedbyconventionaltrabeculectomywithoutdrainagedeviceforneovascularglaucoma
AT limeng preoperativeintravitrealranibizumabwithpanretinalphotocoagulationfollowedbyconventionaltrabeculectomywithoutdrainagedeviceforneovascularglaucoma
AT xiaojinchen preoperativeintravitrealranibizumabwithpanretinalphotocoagulationfollowedbyconventionaltrabeculectomywithoutdrainagedeviceforneovascularglaucoma
AT zhanjunyan preoperativeintravitrealranibizumabwithpanretinalphotocoagulationfollowedbyconventionaltrabeculectomywithoutdrainagedeviceforneovascularglaucoma
AT keweisong preoperativeintravitrealranibizumabwithpanretinalphotocoagulationfollowedbyconventionaltrabeculectomywithoutdrainagedeviceforneovascularglaucoma
_version_ 1718417549378453504